Profil bibliographique

Maureen Reiner

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

73Publications signalées

2009Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Neutropenia and Cancer InfectionsBlood disorders and treatmentsCancer Treatment and PharmacologyColorectal Cancer Treatments and StudiesImmune Response and Inflammation

Publications récentes

2026 erratumOpenAlex

Corrigendum to “A review of relative dose intensity and survival in patients with metastatic solid tumors” [Crit. Rev. Oncol. Hematol. 93 (2015) 203–210]

Laura J. Havrilesky, Maureen Reiner, Phuong Khanh Morrow, Holly Howe Watson et autres

0 citationsCritical Reviews in Oncology/Hematology

Accès ouvert 2022 articleOpenAlex

A retrospective observational study of osteoporosis management after a fragility fracture in primary care

Alan Bell, David L. Kendler, Aliya Khan, Marla Shapiro et autres

15 citationsArchives of Osteoporosis

Accès ouvert 2022 articleOpenAlex

Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study

Milan Gupta, G.B. John Mancini, Rajvi J. Wani, Vineeta Ahooja et autres

39 citationsCJC Open

Accès ouvert 2021 articleOpenAlex

Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada

Jonathan D. Adachi, Jacques P. Brown, Emil H. Schemitsch, Jean‐Éric Tarride et autres

57 citationsBMC Musculoskeletal Disorders

Accès ouvert 2021 articleOpenAlex

Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario

Jacques P. Brown, Jonathan D. Adachi, Emil H. Schemitsch, Jean‐Éric Tarride et autres

108 citationsBMC Musculoskeletal Disorders

2019 conference-abstractOpenAlex

A retrospective observational study assessing bone metastases (mets) detection and management of patients (pts) with castration-resistant prostate cancer (CRPC) in Canada.

Fred Saad, Anil Kapoor, Armen Aprikian, Richard Casey et autres

0 citationsJournal of Clinical Oncology

2018 articleOpenAlex

A Randomized, Single-Blind Study Evaluating the Effect of a Bone Pain Education Video on Reported Bone Pain in Patients with Breast Cancer Receiving Chemotherapy and Pegfilgrastim

Andrew S Guinigundo, Cathy Maxwell, Linda Vanni, Phuong K. Morrow et autres

1 citationPain Management Nursing

2018 articleOpenAlex

A Time-Motion Observational Study of Clinic Staff: Administration of Pegfilgrastim Primary Prophylaxis Via Next-Day Manual Injection and On-Body Injector (OBI)

M.D. Hatfield, Solveig Klæbo Reitan, Lauren Moser, David Chandler et autres

1 citationValue in Health

Accès ouvert 2017 articleOpenAlex

NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim

Jeffrey J. Kirshner, Maxwell C. McDonald, Flavio Kruter, Andrew S Guinigundo et autres

41 citationsSupportive Care in Cancer

Accès ouvert 2017 reviewOpenAlex

A systematic literature review of the efficacy, effectiveness, and safety of filgrastim

David C. Dale, Jeffrey Crawford, Zandra Klippel, Maureen Reiner et autres

102 citationsSupportive Care in Cancer

2017 reviewOpenAlex

The effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic review

Gary H. Lyman, Kim Allcott, Jacob Garcia, Scott Stryker et autres

46 citationsSupportive Care in Cancer

2016 articleOpenAlex

Performance of the pegfilgrastim on-body injector as studied with placebo buffer in healthy volunteers

Rajeshree S. Joshi, Ogo Egbuna, Alex S. Cairns, Michael Jan Friedman et autres

24 citationsCurrent Medical Research and Opinion

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.